Non-coding 886 (nc886/vtRNA2-1), the epigenetic odd duck – implications for future studies

References

• Marttila S, Viiri LE, Mishra PP. et al. Methylation status of nc886 epiallele reflects periconceptional conditions and is associated with glucose metabolism through nc886 RNAs. Clin Epigenetics 2021;13(1). doi: 10.1186/s13148-021-01132-3
   Web of Science ®Google Scholar
• Zink F, et al. Insights into imprinting from parent-of-origin phased methylomes and transcriptomes. Nature Genet. 2018;50(11):1542–20. doi: 10.1038/s41588-018-0232-7
   PubMed Web of Science ®Google Scholar
• Dugué PA, Yu C, McKay T, et al. vtRNA2‐1: genetic variation, heritable methylation and disease association. Int J Mol Sci. 2021;22(5):1–18. doi: 10.3390/ijms22052535
   Web of Science ®Google Scholar
• Dowty JG, et al. Heritable methylation marks associated with prostate cancer risk. Fam Cancer. 2023;22(3):313–317. doi: 10.1007/s10689-022-00325-w
   PubMed Web of Science ®Google Scholar
• Dugué PA, et al. Heritable methylation marks associated with breast and prostate cancer risk. Prostate. 2018;78(13):962–969. doi: 10.1002/pros.23654
   PubMed Web of Science ®Google Scholar
• Marttila S, et al. Methylation status of vtRNA2-1/nc886 is stable across human populations, monozygotic twin pairs and in majority of somatic tissues. 2022. doi: 10.1101/2022.06.21.496995
   Google Scholar
• Carpenter BL, et al. Mother–child transmission of epigenetic information by tunable polymorphic imprinting. Proc Natl Acad Sci, USA. 2018;115(51). doi: 10.1073/pnas.1815005115
   Web of Science ®Google Scholar
• Carpenter BL, et al. Oocyte age and preconceptual alcohol use are highly correlated with epigenetic imprinting of a noncoding RNA (nc886). Proc Natl Acad Sci, USA. 2021;118(12). doi: 10.1073/pnas.2026580118
   Web of Science ®Google Scholar
• Fort RS, Garat B, Sotelo-Silveira JR, et al. vtRNA2-1/nc886 produces a small RNA that contributes to its tumor suppression action through the microRNA pathway in prostate cancer. Noncoding RNA. 2020;6(1):7. doi: 10.3390/ncrna6010007
   PubMed Web of Science ®Google Scholar
• Lee YS. Are we studying non-coding RNAs correctly? Lessons from nc886. Int J Mol Sci. 2022;23(8):4251. doi: 10.3390/ijms23084251
   PubMed Web of Science ®Google Scholar
• Treppendahl MB, Qiu X, Søgaard A, et al. Allelic methylation levels of the noncoding vtRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood. 2012;119(1):206–216. doi: 10.1182/blood-2011-06-362541
   PubMed Web of Science ®Google Scholar
• Park J-L, Lee Y-S, Song M-J, et al. Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesis. Oncogene. 2017;36(49):6793–6804. doi: 10.1038/onc.2017.285
   PubMed Web of Science ®Google Scholar
• Silver MJ, et al. Independent genomewide screens identify the tumor suppressor vtRNA2-1 as a human epiallele responsive to periconceptional environment. Genome Bio. 2015;16(1). doi: 10.1186/s13059-015-0660-y
   PubMedGoogle Scholar
• Finer S, Iqbal MS, Lowe R, et al. Is famine exposure during developmental life in rural Bangladesh associated with a metabolic and epigenetic signature in young adulthood? A historical cohort study. BMJ Open. 2016;6(11):e011768. doi: 10.1136/bmjopen-2016-011768
   PubMed Web of Science ®Google Scholar
• Lee Y-S, Lee YS. nc886, an RNA polymerase III-Transcribed noncoding RNA whose expression is dynamic and regulated by intriguing mechanisms. Int J Mol Sci. 2023;24(10):8533. doi: 10.3390/ijms24108533
   PubMed Web of Science ®Google Scholar
• Minones-Moyano E, Friedländer MR, Pallares J, et al. Upregulation of a small vault RNA (vtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction. RNA Biol. 2013;10(7):1093–1106. doi: 10.4161/rna.24813
   PubMed Web of Science ®Google Scholar
• Barker DJP, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in england and WALES. Lancet. 1986;327(8489):1077–1081. doi: 10.1016/S0140-6736(86)91340-1
   Google Scholar
• Landgraf P, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129(7):1401–1414. doi: 10.1016/j.cell.2007.04.040
   PubMed Web of Science ®Google Scholar
• Yue J, Sheng Y, Orwig KE. Identification of novel homologous microRNA genes in the rhesus macaque genome. BMC Genomics. 2008;9(1):8. doi: 10.1186/1471-2164-9-8
   PubMedGoogle Scholar
• Ambros V, Bartel B, Bartel DP, et al. A uniform system for microRNA annotation. RNA. 2003;9(3):277–279. doi: 10.1261/rna.2183803
   PubMed Web of Science ®Google Scholar
• Stadler PF, et al. Evolution of vault RNAs. Mol Biol Evol. 2009;26(9):1975–1991. doi: 10.1093/molbev/msp112
   PubMed Web of Science ®Google Scholar
• Nandy C, Mrázek J, Stoiber H, et al. Epstein–barr virus-induced expression of a novel human vault RNA. J Mol Biol. 2009;388(4):776–784. doi: 10.1016/j.jmb.2009.03.031
   PubMed Web of Science ®Google Scholar
• Mrázek J, Kreutmayer SB, Grässer FA, et al. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res. 2007;35(10):e73. doi: 10.1093/nar/gkm244
   PubMed Web of Science ®Google Scholar
• Gallo S, Kong E, Ferro I, et al. Small but powerful: the human vault RNAs as multifaceted modulators of pro-survival characteristics and tumorigenesis. Cancers (Basel). 2022;14(11):2787. doi: 10.3390/cancers14112787
   PubMed Web of Science ®Google Scholar
• Lee K, et al. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA. 2011;17(6):1076–1089. doi: 10.1261/rna.2701111
   PubMed Web of Science ®Google Scholar
• Canella D, Praz V, Reina JH, et al. Defining the RNA polymerase III transcriptome: genome-wide localization of the RNA polymerase III transcription machinery in human cells. Genome Res. 2010;20(6):710–721. doi: 10.1101/gr.101337.109
   PubMed Web of Science ®Google Scholar
• Kostiniuk D, Tamminen H, Mishra PP, et al. Methylation pattern of polymorphically imprinted nc886 is not conserved across mammalia. PloS One. 2022;17(3):e0261481. doi: 10.1371/journal.pone.0261481
   PubMed Web of Science ®Google Scholar
• Kunkeaw N, Lee Y-S, Im WR, et al. Mechanism mediated by a noncoding RNA, nc886, in the cytotoxicity of a DNA-reactive compound. Proc Natl Acad Sci USA. 2019;116(17):8289–8294. doi: 10.1073/pnas.1814510116
   PubMed Web of Science ®Google Scholar
• Ahn J-H, Lee H-S, Lee J-S, et al. nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer. Nat Commun. 2018;9(1):1166. doi: 10.1038/s41467-018-03556-7
   PubMedGoogle Scholar
• Kunkeaw N, Jeon SH, Lee K, et al. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene. 2013;32(32):3722–3731. doi: 10.1038/onc.2012.382
   PubMed Web of Science ®Google Scholar
• Calderon BM, Conn GL. Human noncoding RNA 886 (nc886) adopts two structurally distinct conformers that are functionally opposing regulators of PKR. RNA. 2017;23(4):557–566. doi: 10.1261/rna.060269.116
   PubMed Web of Science ®Google Scholar
• Calderon BM, Conn GL. A human cellular noncoding RNA activates the antiviral protein 2′–5′-oligoadenylate synthetase 1. J Biol Chem. 2018;293(41):16115–16124. doi: 10.1074/jbc.RA118.004747
   PubMed Web of Science ®Google Scholar
• Lee YS. A novel type of non-coding RNA, nc886, implicated in tumor sensing and suppression. Genomics Inform. 2015;13(2):26. doi: 10.5808/gi.2015.13.2.26
   PubMedGoogle Scholar
• Sharbati J, et al. Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon mycobacterium avium subsp. hominissuis infection. PLoS One. 2011;6(5):e20258. doi: 10.1371/journal.pone.0020258
   PubMed Web of Science ®Google Scholar
• Saruuldalai E, Park J, Kang D, et al. A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus. Mol Ther Oncolytics. 2022;24:683–694. doi: 10.1016/j.omto.2022.02.018
   PubMed Web of Science ®Google Scholar
• Lee Y-S, Bao X, Lee H-H, et al. Nc886, a novel suppressor of the type I interferon response upon pathogen intrusion. Int J Mol Sci. 2021;22(4):2003. doi: 10.3390/ijms22042003
   PubMed Web of Science ®Google Scholar
• Fort RS, Duhagon MA. Pan-cancer chromatin analysis of the human vtRNA genes uncovers their association with cancer Biology. 2021. doi: 10.12688/f1000research.28510.2
   Google Scholar
• Yu S, et al. Microarray analysis of differentially expressed microRnas in allergic rhinitis. Am J Rhinol Allergy. 2011. doi: 10.2500/ajra.2011.25.3682
   PubMed Web of Science ®Google Scholar
• Suojalehto H, Lindström I, Majuri M-L, et al. Altered microRNA expression of nasal mucosa in long-term asthma and allergic rhinitis. Int Arch Allergy Immunol. 2014;163(3):168–178. doi: 10.1159/000358486
   PubMed Web of Science ®Google Scholar
• Lee K-S, Cho E, Weon JB, et al. Inhibition of UVB-Induced inflammation by laminaria japonica extract via regulation of nc886-PKR pathway. Nutrients. 2020;12(7):1958. doi: 10.3390/nu12071958
   PubMed Web of Science ®Google Scholar
• Lee K-S, Shin S, Cho E, et al. nc886, a non-coding RNA, inhibits UVB-induced MMP-9 and COX-2 expression via the PKR pathway in human keratinocytes. Biochem Biophys Res Commun. 2019;512(4):647–652. doi: 10.1016/j.bbrc.2019.01.068
   PubMed Web of Science ®Google Scholar
• Joo JE, et al. Heritable DNA methylation marks associated with susceptibility to breast cancer. Nat Commun 2018;9(1). doi: 10.1038/s41467-018-03058-6
   Google Scholar
• Romanelli V, et al. Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer. Epigenetics. 2014;9(5):783–790. doi: 10.4161/epi.28323
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhang H, Tang L, et al. Silencing nc886, a non-coding RNA, induces apoptosis of human endometrial cancer cells-1A in vitro. Med Sci Monit. 2017;23:1317–1324. doi: 10.12659/MSM.900320
   PubMed Web of Science ®Google Scholar
• Ross JP, van Dijk S, Phang M, et al. Batch-effect detection, correction and characterisation in Illumina HumanMethylation450 and MethylationEPIC BeadChip array data. Clin Epigenetics. 2022;14(1):58. doi: 10.1186/s13148-022-01277-9
   PubMed Web of Science ®Google Scholar
• Lewis A, Reik W. How imprinting centres work. Cytogenet Genome Res. 2006;113(1–4):81–89. doi: 10.1159/000090818
   PubMed Web of Science ®Google Scholar
• Pervjakova N, Kasela S, Morris AP, et al. Imprinted genes and imprinting control regions show predominant intermediate methylation in adult somatic tissues. Epigenomics. 2016;8(6):789–799. doi: 10.2217/epi.16.8
   PubMed Web of Science ®Google Scholar
• Monk D. Germline-derived DNA methylation and early embryo epigenetic reprogramming: the selected survival of imprints. Int J Biochem Cell Biol. 2015;67:128–138. doi: 10.1016/j.biocel.2015.04.014
   PubMed Web of Science ®Google Scholar
• Baran Y, Subramaniam M, Biton A, et al. The landscape of genomic imprinting across diverse adult human tissues. Genome Res. 2015;25(7):927–936. doi: 10.1101/gr.192278.115
   PubMed Web of Science ®Google Scholar
• Sanchez-Delgado M, Court F, Vidal E, et al. Human oocyte-derived methylation differences persist in the placenta revealing widespread transient imprinting. PloS Genet. 2016;12(11):e1006427. doi: 10.1371/journal.pgen.1006427
   PubMed Web of Science ®Google Scholar
• Carli D, Riberi E, Ferrero GB, et al. Syndromic disorders caused by disturbed human imprinting. J Clin Res Pediatr Endocrinol. 2020;12(1):1–16. doi: 10.4274/jcrpe.galenos.2019.2018.0249
   PubMed Web of Science ®Google Scholar
• Olsen KW, Castillo-Fernandez J, Zedeler A, et al. A distinctive epigenetic ageing profile in human granulosa cells. Hum Reprod. 2020;35(6):1332–1345. doi: 10.1093/humrep/deaa071
   PubMed Web of Science ®Google Scholar
• Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484–492. doi: 10.1038/nrg3230
   PubMed Web of Science ®Google Scholar
• Lee H-S, Lee K, Jang H-J, et al. Epigenetic silencing of the non-coding RNA nc886 provokes oncogenes during human esophageal tumorigenesis. Oncotarget. 2014;5(11):3472–3481. doi: 10.18632/oncotarget.1927
   PubMedGoogle Scholar
• Lee K-S, Park J-L, Lee K, et al. nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer. Oncotarget. 2014;5(11):3944–3955. doi: 10.18632/oncotarget.2047
   PubMedGoogle Scholar
• Sallustio F, Serino G, Cox S, et al. Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy. Clin Sci. 2016;130(9):733–746. doi: 10.1042/CS20150711
   Web of Science ®Google Scholar
• Court F, Tayama C, Romanelli V, et al. Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment. Genome Res. 2014;24(4):554–569. doi: 10.1101/gr.164913.113
   PubMed Web of Science ®Google Scholar
• Okae H, Chiba H, Hiura H, et al. Genome-wide analysis of DNA methylation dynamics during early human development. PloS Genet. 2014;10(12):e1004868. doi: 10.1371/journal.pgen.1004868
   PubMed Web of Science ®Google Scholar
• Jima DD, Skaar DA, Planchart A, et al. Genomic map of candidate human imprint control regions: the imprintome. Epigenetics. 2022;17(13):1920–1943. doi: 10.1080/15592294.2022.2091815
   PubMed Web of Science ®Google Scholar
• Zhu P, Guo H, Ren Y, et al. Single-cell DNA methylome sequencing of human preimplantation embryos. Nat Genet. 2018;50(1):12–19. doi: 10.1038/s41588-017-0007-6
   PubMed Web of Science ®Google Scholar
• Obata Y, Kono T. Maternal primary imprinting is established at a specific time for each gene throughout oocyte growth*. J Biol Chem. 2002;277(7):5285–5289. doi: 10.1074/jbc.M108586200
   PubMed Web of Science ®Google Scholar
• Guo H, Zhu P, Yan L, et al. The DNA methylation landscape of human early embryos. Nature. 2014;511(7511):606–610. doi: 10.1038/nature13544
   PubMed Web of Science ®Google Scholar
• You Y-A, Kwon EJ, Hwang H-S, et al. Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth. BMC Genomics. 2021;22(1):528. doi: 10.1186/s12864-021-07865-y
   PubMed Web of Science ®Google Scholar
• Gopalan S, Carja O, Fagny M, et al. Trends in DNA methylation with age replicate across diverse human populations. Genetics. 2017;206(3):1659–1674. doi: 10.1534/genetics.116.195594
   PubMed Web of Science ®Google Scholar
• Heyn H, Moran S, Hernando-Herraez I, et al. DNA methylation contributes to natural human variation. Genome Res. 2013;23(9):1363–1372. doi: 10.1101/gr.154187.112
   PubMed Web of Science ®Google Scholar
• Fagny M, Patin E, MacIsaac JL, et al. The epigenomic landscape of African rainforest hunter-gatherers and farmers. Nat Commun. 2015;6(1):10047. doi: 10.1038/ncomms10047
   PubMedGoogle Scholar
• Natri HM, Bobowik KS, Kusuma P, et al. Genome-wide DNA methylation and gene expression patterns reflect genetic ancestry and environmental differences across the Indonesian archipelago. PLoS Genet. 2020;16(5):e1008749. doi: 10.1371/journal.pgen.1008749
   PubMed Web of Science ®Google Scholar
• Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell. 2019;177(1):26–31. doi: 10.1016/j.cell.2019.02.048
   PubMed Web of Science ®Google Scholar
• Markunas CA, et al. Maternal age at delivery is associated with an epigenetic signature in both newborns and adults. PLoS One. 2016;11(7):e0156361. doi: 10.1371/journal.pone.0156361
   PubMed Web of Science ®Google Scholar
• Richmond RC, Sharp GC, Herbert G, et al. The long-term impact of folic acid in pregnancy on offspring DNA methylation: follow-up of the aberdeen folic acid supplementation trial (AFAST). Int J Epidemiol. 2018;47(3):928–937. doi: 10.1093/ije/dyy032
   PubMed Web of Science ®Google Scholar
• Van Der Plaat DA, et al. Occupational exposure to pesticides is associated with differential DNA methylation. Occup Environ Med. 2018;75(6):427–435. doi: 10.1136/oemed-2017-104787
   PubMed Web of Science ®Google Scholar
• van der Plaat DA, Vonk JM, Terzikhan N, et al. Occupational exposure to gases/fumes and mineral dust affect DNA methylation levels of genes regulating expression. Hum Mol Genet. 2019;28(15):2477–2485. doi: 10.1093/hmg/ddz067
   PubMed Web of Science ®Google Scholar
• Ambatipudi S, Cuenin C, Hernandez-Vargas H, et al. Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study. Epigenomics. 2016;8(5):599–618. doi: 10.2217/epi-2016-0001
   PubMed Web of Science ®Google Scholar
• Xu R, Li S, Wu Y, et al. Wildfire-related PM2.5 and DNA methylation: an Australian twin and family study. Environ Int. 2023;171:107704. doi: 10.1016/j.envint.2022.107704
   PubMed Web of Science ®Google Scholar
• Eze IC, Jeong A, Schaffner E, et al. Genome-wide DNA methylation in peripheral blood and long-term exposure to source-specific transportation noise and air pollution: the SAPALDIA study. Environ Health Perspect. 2020;128(6):067003. doi: 10.1289/EHP6174
   PubMed Web of Science ®Google Scholar
• Tobi EW, Goeman JJ, Monajemi R, et al. DNA methylation signatures link prenatal famine exposure to growth and metabolism. Nat Commun. 2014;5(1):5592. doi: 10.1038/ncomms6592
   PubMedGoogle Scholar
• Peter CJ, Fischer LK, Kundakovic M, et al. DNA methylation signatures of early childhood malnutrition associated with impairments in attention and cognition. Biological Psychiatry. 2016;80(10):765–774. doi: 10.1016/j.biopsych.2016.03.2100
   PubMed Web of Science ®Google Scholar
• Boks MP, Houtepen LC, Xu Z, et al. Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia. NPJ Schizophr. 2018;4(1):1–8. doi: 10.1038/s41537-018-0058-4
   PubMedGoogle Scholar
• Van Dijk SJ, Peters TJ, Buckley M, et al. DNA methylation in blood from neonatal screening cards and the association with BMI and insulin sensitivity in early childhood. Int J Obesity. 2018;42(1):28–35. doi: 10.1038/ijo.2017.228
   PubMed Web of Science ®Google Scholar
• Gonseth S, Shaw GM, Roy R, et al. Epigenomic profiling of newborns with isolated orofacial clefts reveals widespread DNA methylation changes and implicates metastable epiallele regions in disease risk. Epigenetics. 2019;14(2):198–213. doi: 10.1080/15592294.2019.1581591
   PubMed Web of Science ®Google Scholar
• Henderson AR, Wang Q, Meechoovet B, et al. DNA methylation and expression profiles of whole blood in Parkinson’s disease. Front Genet. 2021;12. doi: 10.3389/fgene.2021.640266
   Web of Science ®Google Scholar
• Chuang YH, Paul KC, Bronstein JM, et al. Parkinson’s disease is associated with DNA methylation levels in human blood and saliva. Genome Med. 2017;9(1). doi: 10.1186/s13073-017-0466-5
   Google Scholar
• Vallerga CL, Zhang F, Fowdar J, et al. Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease. Nat Commun. 2020;11(1):1238. doi: 10.1038/s41467-020-15065-7
   PubMed Web of Science ®Google Scholar
• Sallustio F, Picerno A, Cimmarusti MT, et al. Elevated levels of IL-6 in IgA nephropathy patients are induced by an epigenetically driven mechanism modulated by viral and bacterial RNA. Eur J Internal Med. 2023;118:108–117. doi: 10.1016/j.ejim.2023.07.045
   PubMed Web of Science ®Google Scholar
• Li JH, Xiao X, Zhang Y-N, et al. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol Oncol. 2011;120(1):145–151. doi: 10.1016/j.ygyno.2010.09.009
   PubMed Web of Science ®Google Scholar
• Kong L, Hao Q, Wang Y, et al. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells. Oncotarget. 2015;6(29):28371–28388. doi: 10.18632/oncotarget.4948
   PubMedGoogle Scholar
• Li J-H, Wang M, Zhang R, et al. E2F1-directed activation of nc886 mediates drug resistance in cervical cancer cells via regulation of major vault protein. Int J Clin Exp Pathol. 2017;10(9):9233–9242.
   PubMed Web of Science ®Google Scholar
• Zhang L-L, Wu J, Liu Q, et al. MiR-886-5p inhibition inhibits growth and induces apoptosis of MCF7 cells. Asian Pac J Cancer Prev. 2014;15(4):1511–1515. doi: 10.7314/APJCP.2014.15.4.1511
   PubMedGoogle Scholar
• Khoshnevisan A, Parvin M, Ghorbanmehr N, et al. A significant upregulation of miR-886-5p in high grade and invasive bladder tumors. Urol J. 2015;12(3):2160–2164.
   PubMed Web of Science ®Google Scholar
• McDonald AC, Vira M, Walter V, et al. Circulating microRnas in plasma among men with low-grade and high-grade prostate cancer at prostate biopsy. Prostate. 2019;79(9):961–968. doi: 10.1002/pros.23803
   PubMed Web of Science ®Google Scholar
• Pan B, Yu J, Liu X. Upregulation of miR-886 indicates poor prognosis and promotes tumour progression of prostate cancer. Andrologia. 2022;54(1):e14296. doi: 10.1111/and.14296
   PubMed Web of Science ®Google Scholar
• Xiang P, Liu Y, Liu L, et al. The biological function and clinical significance of miR-886-5p in multiple myeloma. AHA. 2019;142(4):208–216. doi: 10.1159/000499620
   Google Scholar
• Lei J, Xiao J-H, Zhang S-H, et al. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the janus kinase 2/signal transducer and activator of transcription 3 signaling pathway. Mol Med Rep. 2017;16(4):4273–4278. doi: 10.3892/mmr.2017.7093
   PubMed Web of Science ®Google Scholar
• Jang H-J, Lee H-S, Burt BM, et al. Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer. Gut. 2017;66(2):215–225. doi: 10.1136/gutjnl-2015-311238
   PubMed Web of Science ®Google Scholar
• Fort RS, Mathó C, Geraldo MV, et al. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer 2018;18(1). doi: 10.1186/s12885-018-4049-7
   PubMedGoogle Scholar
• Yang R, Zuo L, Ma H, et al. Downregulation of nc886 contributes to prostate cancer cell invasion and TGFβ1-induced EMT. Genes Dis. 2022;9(4):1086–1098. doi: 10.1016/j.gendis.2020.12.010
   PubMed Web of Science ®Google Scholar
• Liang S, et al. Screening and identification of potential miRNA involved in ovarian cancer invasion and metastasis. Zhonghua Zhong Liu Za Zhi. 2010;32(9):650–654.
   PubMedGoogle Scholar
• Tahiri A, Leivonen S-K, Lüders T, et al. Deregulation of cancer-related miRnas is a common event in both benign and malignant human breast tumors. Carcinogenesis. 2014;35(1):76–85. doi: 10.1093/carcin/bgt333
   PubMed Web of Science ®Google Scholar
• Xiong Y, et al. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One. 2011;6(10):e24717. doi: 10.1371/journal.pone.0024717
   PubMed Web of Science ®Google Scholar
• Dettmer MS, et al. MicroRNA profile of poorly differentiated thyroid carcinomas – new diagnostic and prognostic insights. J Mol Endocrinol. 2014;52(2):181–189. doi: 10.1530/JME-13-0266
   PubMed Web of Science ®Google Scholar
• Bi N, Cao J, Song Y, et al. A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy. PLoS One. 2014;9(3):e91388. doi: 10.1371/journal.pone.0091388
   PubMed Web of Science ®Google Scholar
• Gao W, Shen H, Liu L, et al. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol. 2011;137(4):557–566. doi: 10.1007/s00432-010-0918-4
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang X, Han S, et al. Suppression of mir-886-3P mediated by Arecoline (are) contributes to the progression of oral squamous cell carcinoma. J Invest Med. 2021;69(2):377–381. doi: 10.1136/jim-2020-001405
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang Z, Wei P, et al. Hypermethylation of nc886 in HPV-positive oropharyngeal cancer and its clinical implications: an epigenome-wide association study. Mol Ther Nucleic Acids. 2022;30:596–605. doi: 10.1016/j.omtn.2022.11.012
   PubMedGoogle Scholar
• Im WR, Lee H-S, Lee Y-S, et al. A regulatory noncoding RNA, nc886, suppresses esophageal cancer by inhibiting the AKT pathway and cell cycle progression. Cells. 2020;9(4):801. doi: 10.3390/cells9040801
   PubMed Web of Science ®Google Scholar
• Gao W, Zhang S, Guorong L, et al. Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation. Cell Cycle. 2022;21(4):340–351. doi: 10.1080/15384101.2021.2020431
   PubMed Web of Science ®Google Scholar
• Nordentoft I, Birkenkamp-Demtroder K, Agerbæk M, et al. miRnas associated with chemo-sensitivity in cell lines and in advanced bladder cancer. BMC Med Genomics. 2012;5(1):40. doi: 10.1186/1755-8794-5-40
   PubMedGoogle Scholar
• Cao J, et al. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cancer Res. 2013;73(11):3326–3335. doi: 10.1158/0008-5472.CAN-12-3055
   PubMed Web of Science ®Google Scholar
• Shen J, Zhou W, Bi N, et al. MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer. Cancer Biol Ther. 2018;19(12):1185–1192. doi: 10.1080/15384047.2018.1491505
   PubMed Web of Science ®Google Scholar
• Schou JV, Rossi S, Jensen BV, et al. miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and Irinotecan. PLoS One. 2014;9(6):e99886. doi: 10.1371/journal.pone.0099886
   PubMed Web of Science ®Google Scholar
• Okumura T, Kojima H, Miwa T, et al. The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 2016;14(1):228. doi: 10.1186/s12957-016-0985-3
   PubMedGoogle Scholar
• Lee EK, et al. Nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer. Oncotarget. 2016;7(46):75000–75012. doi: 10.18632/oncotarget.11852
   PubMedGoogle Scholar
• Ortega-García MB, et al. Uncovering tumour heterogeneity through PKR and nc886 analysis in metastatic colon cancer patients treated with 5-FU-based chemotherapy. Cancers (Basel). 2020;12(2):379. doi: 10.3390/cancers12020379
   PubMed Web of Science ®Google Scholar
• Han Z-B, Zhong L, Teng M-J, et al. Identification of recurrence-related microRnas in hepatocellular carcinoma following liver transplantation. Mol Oncol. 2012;6(4):445–457. doi: 10.1016/j.molonc.2012.04.001
   PubMed Web of Science ®Google Scholar
• Yu M-C, Lee C-W, Lin C-H, et al. Differential hypermethylation of the vtRNA2-1 promoter in hepatocellular carcinoma as a prognostic factor: tumor marker prognostic study. Int J Surg. 2020;79:282–289. doi: 10.1016/j.ijsu.2020.05.016
   PubMed Web of Science ®Google Scholar
• Wang Z, Lu Y, Fornage M, et al. Identification of novel susceptibility methylation loci for pancreatic cancer in a two-phase epigenome-wide association study. Epigenetics. 2022;17(11):1357–1372. doi: 10.1080/15592294.2022.2026591
   PubMed Web of Science ®Google Scholar
• Paliwal A, et al. Comparative anatomy of chromosomal domains with imprinted and non-imprinted allele-specific DNA methylation. PLoS Genet. 2013;9(8):e1003622. doi: 10.1371/journal.pgen.1003622
   PubMed Web of Science ®Google Scholar
• Van Baak TE, et al. Epigenetic supersimilarity of monozygotic twin pairs. Genome Bio. 2018;19(2). doi: 10.1186/s13059-017-1374-0
   PubMedGoogle Scholar
• Schulze KV, Swaminathan S, Howell S, et al. Edematous severe acute malnutrition is characterized by hypomethylation of DNA. Nat Commun. 2019;10(1):5791. doi: 10.1038/s41467-019-13433-6
   PubMedGoogle Scholar
• Kho M, et al. Epigenetic loci for blood pressure are associated with hypertensive target organ damage in older African Americans from the genetic epidemiology network of arteriopathy (GENOA) study. BMC Med Genomics. 2020;13(1):131. doi: 10.1186/s12920-020-00791-0
   PubMed Web of Science ®Google Scholar
• Quinn EB, Hsiao CJ, Maisha FM, et al. Prenatal maternal stress is associated with site-specific and age acceleration changes in maternal and newborn DNA methylation. Epigenetics. 2023;18(1):2222473. doi: 10.1080/15592294.2023.2222473
   PubMed Web of Science ®Google Scholar
• Galanter JM, Gignoux CR, Oh SS, et al. Differential methylation between ethnic sub-groups reflects the effect of genetic ancestry and environmental exposures. Elife. 2017;6:e20532. doi: 10.7554/eLife.20532
   PubMed Web of Science ®Google Scholar
• Xiu J, Li J, Liu Z, et al. Elevated BICD2 DNA methylation in blood of major depressive disorder patients and reduction of depressive-like behaviors in hippocampal Bicd2-knockdown mice. Proc Natl Acad Sci U S A. 2022;119(30):e2201967119. doi: 10.1073/pnas.2201967119
   PubMed Web of Science ®Google Scholar
• Kao W-Y, Yang S-H, Liu W-J, et al. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers. Mol Carcinog. 2017;56(2):425–435. doi: 10.1002/mc.22505
   PubMed Web of Science ®Google Scholar
• Horvath S, Ritz BR. Increased epigenetic age and granulocyte counts in the blood of Parkinson’s disease patients. Aging (Albany NY). 2015;7:1130–1142. doi:10.18632/aging.100859
   PubMedGoogle Scholar
• Horvath S, et al. Huntington’s disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels. Aging (Albany NY). 2016;8:1485–1512. doi: 10.18632/aging.101005
   PubMedGoogle Scholar
• Hannum G, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Molecular Cell. 2013;49(2):359–367. doi: 10.1016/j.molcel.2012.10.016
   PubMed Web of Science ®Google Scholar
• Horvath S, Erhart W, Brosch M, et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci USA. 2014;111(43):15538–15543. doi: 10.1073/pnas.1412759111
   PubMed Web of Science ®Google Scholar
• Johnson ND, Wu X, Still CD, et al. Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD. Clin Epigenetics. 2021;13(1):152. doi: 10.1186/s13148-021-01129-y
   PubMed Web of Science ®Google Scholar
• Roos L, Sandling JK, Bell CG, et al. Higher nevus Count exhibits a distinct DNA methylation signature in healthy human skin: implications for melanoma. J Invest Dermatol. 2017;137(4):910–920. doi: 10.1016/j.jid.2016.11.029
   PubMed Web of Science ®Google Scholar
• Kirby MK, Ramaker RC, Roberts BS, et al. Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns. BMC Cancer. 2017;17(1):273. doi: 10.1186/s12885-017-3252-2
   PubMedGoogle Scholar
• Oliva M, Demanelis K, Lu Y, et al. DNA methylation QTL mapping across diverse human tissues provides molecular links between genetic variation and complex traits. Nat Genet. 2023;55(1):112–122. doi: 10.1038/s41588-022-01248-z
   PubMed Web of Science ®Google Scholar
• Johnson KC, Houseman EA, King JE, et al. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age. Breast Cancer Res. 2017;19(1):81. doi: 10.1186/s13058-017-0873-y
   PubMedGoogle Scholar
• Song M-A, Brasky TM, Weng DY, et al. Landscape of genome-wide age-related DNA methylation in breast tissue. Oncotarget. 2017;8(70):114648–114662. doi: 10.18632/oncotarget.22754
   PubMedGoogle Scholar
• Wei J-H, Haddad A, Wu K-J, et al. A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015;6(1):8699. doi: 10.1038/ncomms9699
   PubMedGoogle Scholar